According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.11. In 2022 the company made an earnings per share (EPS) of -$4.12 a decrease over its 2021 EPS that were of -$2.95.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.87 | -6.09% |
2022 | -$4.12 | 39.81% |
2021 | -$2.95 | 22.84% |
2020 | -$2.40 |